Effective Dose of Epidural Hydromorphone for Analgesia Following Caesarean Section in Using Modified Dixon Sequential Method
Qiao-Qiao Liu,Mao Mao,Ning-Hua Lin,Chen-Yang Xu,Qian Li,Chang-Shuo Jiang,Shan-Wu Feng,Hong-Mei Yuan
DOI: https://doi.org/10.2147/jpr.s480917
IF: 2.8319
2024-11-10
Journal of Pain Research
Abstract:Qiao-Qiao Liu, 1, &ast Mao Mao, 1, &ast Ning-Hua Lin, 2, &ast Chen-Yang Xu, 1, &ast Qian Li, 1 Chang-Shuo Jiang, 1 Shan-Wu Feng, 1 Hong-Mei Yuan 1 1 Department of Anesthesiology, Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, Nanjing, 210004, People's Republic of China; 2 Department of Anesthesiology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, People's Republic of China &astThese authors contributed equally to this work Correspondence: Shan-Wu Feng; Hong-Mei Yuan, Department of Anesthesiology, Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, No. 123, Tianfei Lane, Mochou Road, Nanjing, Jiangsu, People's Republic of China, Email ; Background: A single dose of epidural hydromorphone has been suggested as an alternative method for providing analgesia after caesarean section (CS). Nevertheless, the optimal dosage of epidural hydromorphone for postoperative pain relief following CS has yet to be determined. Methods: This trial included 30 singleton primiparous women undergoing scheduled caesarean delivery, who were recruited to determine doses of epidural hydromorphone using the modified Dixon sequential method. The initial hydromorphone dose was 0.75 mg, with adjustments based on the efficacy of the preceding participant's dose over 12 hours. Various parameters such as blood pressure, heart rate, respiratory rate, visual analog scale (VAS) pain score, postoperative adverse reactions, and patient satisfaction with analgesic effect were recorded at each time point. The VAS scores were categorized as positive (score > 3) or negative (score ≤ 3). Participants received a single epidural injection of 0.2% ropivacaine 20 mg along with a study dose of hydromorphone. The median effective dose (ED50), 90% effective dose (ED90), and corresponding 95% confidence intervals (CIs) of hydromorphone with ropivacaine for analgesia after caesarean section were calculated using the probit method. Results: The ED90 and ED50 in our population were 1.105 mg (95% CI: 0.825– 2.324 mg) and 0.659 mg (95% CI: 0.434– 0.883 mg), respectively. Conclusion: Epidural hydromorphone can be safely used for postoperative analgesia in patients undergoing caesarean section, and the analgesic effect is satisfactory when the dosage is appropriate. Keywords: hydromorphone, ropivacaine, caesarean delivery, postoperative analgesia, ED50, ED90 Caesarean section (CS) is often associated with intense postoperative pain and uterine contractions. 1 It is essential to offer women effective pain management options with minimal side effects to help speed up or support their recovery from surgical pain. Epidural administration is considered an important analgesic technique for caesarean delivery, offering better postsurgical pain relief and fewer side effects when compared to intravenous analgesia. 2 Research has demonstrated the clinical effectiveness of epidural opioid analgesics in providing post-caesarean analgesia. 3 However, a long-term indwelling epidural catheter use is also a risk factor for catheter occlusion, catheter migration, or infection. Therefore, it is of great significance to explore single epidural administration for postoperative analgesia. Morphine, the most commonly used opioid, has been proven to be an effective drug with long-lasting effects following epidural administration. 4 While a single epidural injection of morphine can provide successful postoperative analgesia, it is associated with long-term opioid side effects. 5 Hydromorphone, a semisynthetic derivative of morphine, is extensively utilized for managing clinical pain. 6 It offers analgesic effects comparable to morphine but with the added benefit of reducing postoperative itching. 7 Studies have shown its efficacy in providing analgesia after caesarean section when administered epidurally. 8–10 Though epidural hydromorphone provides fast onset and modest duration of action clinically, 11 there are few data on the efficacy of its analgesia after CS. While the dose of 0.6 mg has been reported to reduce the dosage of sufentanil after CS, 12 the single optimal dose is still unknown. The purpose of this study is to determine the median effective dose (ED50) and 90% effective dose (ED90) of epidural hydromorphone in patients undergoing CS. This study was approved by the Ethics Committee of Nanjing Women and Children's Healthcare Hospital (Project number: 2022KY-127, rev -Abstract Truncated-
clinical neurology